This makes thiazolides an interesting novel class of anti-tumor drugs specifically targeting tumors with elevated levels of GSTs, and GSTP1-1 an Achilles' heel for the potential therapeutic action of thiazolides. Here, GSTP1 is linked to neoplasm.